MedicineNeurologyNeuroscienceNeurobiology Of DiseaseNeuropathologyPediatric NeurologyDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisWhite Matter DisordersClinicopathologic FeaturesDemyelinating Disease PathologyDysmyelinating DisordersInflammatory DemyelinationMultiple Sclerosis PathologySchilder DiseaseWhite Matter LesionsWhite Matter Microstructure
Controversy has surrounded the rare clinicopathologic en tity of inflammatory myelinoclastic diffuse sclerosis (IMDS) since the seminal description of Schilder in 1912 [1]. Since that time several distinct myelinoclastic and dysmyelinating conditions have been grouped under this eponym. To this newly described demyelinating disease, the author planted the seeds of an enduring controversy by including two addi tional cases (1913, 1924) [2, 3] that, in retrospect, were shown to be examples of a leukodystrophy and , possibly, subacute sclerosing panencephalitis, respectively. As a result, the evolving eponym Schilder's has come to represent a much wider spectrum of disease than the original 1912 de scription, including examples of adrenoleukodystrophy, acute disseminated encephalomyelitis, transitional sclerosis, and juvenile multiple sclerosis. In the context of recent advances in biochemistry, neuroimaging, and electrophysiology, it has been possible to more systematically separate related disor ders of white matter. This diagnostic reappraisal has allowed the emergence of a rare IMDS that remains faithful to Schild er's original 1912 description. We present only the third fully documented case. The temporal profile spans the entire spectrum of clinical forms of IMDS previously defined by Lhermitte [4]. Because of the rapid and dramatic fluctuations in the patient's functional status, it has been possible to obtain sequential CT and comparative MR scans that graph ically document the interplay of cavitary and diffuse white matter lesions. This has allowed cliniconeuroradiologic assessment of this rare but distinctive inflammatory myelino clastic condition, rigorously defined by biochemical, patho logic, and electrophysiologic criteria.
8
Progressive multifocal leukoencephalopathy: Clinical and radiographic features
Lauren Krupp, Richard B. Lipton, Michael Swerdlow et al. · Annals of Neurology · 1985 · 188 citations
Schilder's Myelinoclastic Diffuse Sclerosis
Charles M. Poser, Françoise Goutières · PEDIATRICS · 1986 · 112 citations
Acquired immunodeficiency syndrome: cerebral computed tomographic manifestations.
M A Whelan, Irvin I. Kricheff, Marc Z. Handler et al. · Radiology · 1983 · 95 citations
Computed Tomography in White-Matter Disease
E. Ralph Heinz, Burton P. Drayer, Charles A. Haenggeli et al. · Radiology · 1979 · 94 citations
Diagnosis of Progressive Multifocal Leukoencephalopathy by Computed Tomography
Barbara A. Carroll, Barton Lane, David Norman et al. · Radiology · 1977 · 81 citations